EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Multizentrische StudieOpen Access · CC BY 4.0

Safety and Immunogenicity of the mRNA-1273 Coronavirus Disease 2019 Vaccine in Solid Organ Transplant Recipients

Amparo L Figueroa, Jamil R Azzi, Bijan Eghtesad, Frances Priddy, Dina Stolman, Uma Siangphoe, Iliana Leony Lasso, Elizabeth de Windt, Bethany Girard, Honghong Zhou, Jacqueline M Miller, Rituparna Das

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiae140 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Amparo L Figueroa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Moderna, Cambridge, Massachusetts, USA. Hauptthemen laut MEDLINE: 2019-nCoV Vaccine mRNA-1273, COVID-19, COVID-19 Vaccines, Organ Transplantation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Solid organ transplant recipients (SOTRs) are at high risk for severe COVID-19.

Methods

This open-label, phase 3b trial evaluated mRNA-1273 in 137 kidney and 77 liver SOTRs and 20 immunocompetent participants. In part A, SOTRs received three 100-µg doses of mRNA-1273; immunocompetent participants received 2 doses. In part B, an additional 100-µg dose was offered ≥4 months after the primary series. Here, we report interim trial results. Results mRNA-1273 was well-tolerated in SOTRs. Four serious adverse events were considered vaccine related by the investigator in 3 SOTRs with preexisting comorbidities. No vaccine-related biopsy-proven organ rejection events or deaths were reported. mRNA-1273 elicited modest neutralizing antibody responses after dose 2 and improved responses after dose 3 in SOTRs. Post–dose 3 responses among liver SOTRs were comparable to post–dose 2 responses in immunocompetent participants. Post-additional dose responses were increased in SOTRs, regardless of primary series vaccination. In liver SOTRs, post-additional dose responses were ∼3-fold higher versus post-dose 2 but lower than immunocompetent participant responses. Most kidney SOTRs received multiple immunosuppressants and had reduced antibody responses versus liver SOTRs. Conclusions mRNA-1273 was well-tolerated, and dose 3 and the additional dose improved antibody responses among SOTRs. Clinical Trials Registration NCT04860297.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

2019-nCoV Vaccine mRNA-1273COVID-19COVID-19 VaccinesOrgan TransplantationSARS-CoV-2Transplant RecipientsAdultAgedFemaleHumansMaleMiddle AgedAntibodies, NeutralizingAntibodies, ViralImmunocompromised HostImmunogenicity, VaccineKidney TransplantationLiver TransplantationVaccination

Stichwörter der Autor:innen

COVID-19immunocompromisedmRNA-1273solid organ transplant recipientsvaccine

Substanzen

2019-nCoV Vaccine mRNA-1273Antibodies, NeutralizingAntibodies, ViralCOVID-19 Vaccines

Autor:innen und Institutionen

  • Moderna, Cambridge, Massachusetts, USA.
  • Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Cleveland Clinic, Cleveland, Ohio, USA.

Zitieren

APA

Figueroa, A. L., Azzi, J. R., Eghtesad, B., Priddy, F., Stolman, D., Siangphoe, U., Leony Lasso, I., de Windt, E., Girard, B., Zhou, H., Miller, J. M., & Das, R. (2024). Safety and Immunogenicity of the mRNA-1273 Coronavirus Disease 2019 Vaccine in Solid Organ Transplant Recipients. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae140

Vancouver

Figueroa AL, Azzi JR, Eghtesad B, Priddy F, Stolman D, Siangphoe U, et al. Safety and Immunogenicity of the mRNA-1273 Coronavirus Disease 2019 Vaccine in Solid Organ Transplant Recipients. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiae140

BibTeX
@article{Figueroa2024,
  author = {Figueroa, Amparo L and Azzi, Jamil R and Eghtesad, Bijan and Priddy, Frances and Stolman, Dina and Siangphoe, Uma and Leony Lasso, Iliana and de Windt, Elizabeth and Girard, Bethany and Zhou, Honghong and Miller, Jacqueline M and Das, Rituparna},
  title = {Safety and Immunogenicity of the mRNA-1273 Coronavirus Disease 2019 Vaccine in Solid Organ Transplant Recipients},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiae140}
}
Kostenlos starten →